MicroRNA-135a Modulates Hepatitis C Virus Genome Replication through Downregulation of Host Antiviral Factors

[1]  P. Murphy,et al.  Multisystem multitasking by CXCL12 and its receptors CXCR4 and ACKR3 , 2018, Cytokine.

[2]  R. El-Diwany,et al.  Cellular microRNA networks regulate host dependency of hepatitis C virus infection , 2017, Nature Communications.

[3]  R. Darnell,et al.  Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer. , 2017, Molecular cell.

[4]  N. Pochet,et al.  miR-135a-5p-mediated downregulation of protein tyrosine phosphatase receptor delta is a candidate driver of HCV-associated hepatocarcinogenesis , 2017, Gut.

[5]  Peter J. Richardson,et al.  Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection , 2016, Hepatology.

[6]  R. Savan,et al.  Landscape of post-transcriptional gene regulation during hepatitis C virus infection. , 2015, Current opinion in virology.

[7]  A. Mele,et al.  Hepatitis C Virus RNA Functionally Sequesters miR-122 , 2015, Cell.

[8]  S. Lemon,et al.  Dissecting the Roles of the 5′ Exoribonucleases Xrn1 and Xrn2 in Restricting Hepatitis C Virus Replication , 2015, Journal of Virology.

[9]  S. Lemon,et al.  miR-122 Stimulates Hepatitis C Virus RNA Synthesis by Altering the Balance of Viral RNAs Engaged in Replication versus Translation , 2015, Cell Host & Microbe.

[10]  S. Pfeffer,et al.  miR-122--a key factor and therapeutic target in liver disease. , 2015, Journal of hepatology.

[11]  P. Sarnow,et al.  Hepatitis C virus subverts liver-specific miR-122 to protect the viral genome from exoribonuclease Xrn2. , 2014, Cell host & microbe.

[12]  D. Tyrrell,et al.  Hepatitis C virus and microRNAs: miRed in a host of possibilities. , 2014, Current opinion in virology.

[13]  B. Cullen,et al.  Replication of Many Human Viruses Is Refractory to Inhibition by Endogenous Cellular MicroRNAs , 2014, Journal of Virology.

[14]  Fang Zhang,et al.  Integrative Functional Genomics of Hepatitis C Virus Infection Identifies Host Dependencies in Complete Viral Replication Cycle , 2014, PLoS pathogens.

[15]  A. Mildner,et al.  RNA viruses can hijack vertebrate microRNAs to suppress innate immunity , 2013, Nature.

[16]  B. Cullen.  How Do Viruses Avoid Inhibition by Endogenous Cellular MicroRNAs? , 2013, PLoS pathogens.

[17]  G. Szabo,et al.  MicroRNAs in liver disease , 2013, Nature Reviews Gastroenterology &Hepatology.

[18]  A. Flaxman,et al.  Global epidemiology of hepatitis C virus infection: New estimates of age‐specific antibody to HCV seroprevalence , 2013, Hepatology.

[19]  S. Lemon,et al.  Competing and noncompeting activities of miR-122 and the 5′ exonuclease Xrn1 in regulation of hepatitis C virus replication , 2012, Proceedings of the National Academy of Sciences.

[20]  D. Xie,et al.  MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma. , 2012, Journal of hepatology.

[21]  Anton P. McCaffrey,et al.  Hepatitis C virus infection and hepatic stellate cell activation downregulate miR-29: miR-29 overexpression reduces hepatitis C viral abundance in culture. , 2011, The Journal of infectious diseases.

[22]  Olivier Poch,et al.  EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy , 2011, Nature Medicine.

[23]  Li Lin,et al.  Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. , 2011, Cancer cell.

[24]  Thomas Lengauer,et al.  Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. , 2011, Cell host & microbe.

[25]  T. Luedde,et al.  Micro‐RNA profiling reveals a role for miR‐29 in human and murine liver fibrosis , 2011, Hepatology.

[26]  W. Filipowicz,et al.  Regulation of mRNA translation and stability by microRNAs. , 2010, Annual review of biochemistry.

[27]  Nicholas T. Ingolia,et al.  Mammalian microRNAs predominantly act to decrease target mRNA levels , 2010, Nature.

[28]  H. Bonkovsky,et al.  MicroRNA‐196 represses Bach1 protein and hepatitis C virus gene expression in human hepatoma cells expressing hepatitis C viral proteins , 2010, Hepatology.

[29]  K. Ishii,et al.  Production of Infectious Hepatitis C Virus by Using RNA Polymerase I-Mediated Transcription , 2010, Journal of Virology.

[30]  Qisheng Li,et al.  A genome-wide genetic screen for host factors required for hepatitis C virus propagation , 2009, Proceedings of the National Academy of Sciences.

[31]  Raymond T Chung,et al.  A functional genomic screen identifies cellular cofactors of hepatitis C virus replication. , 2009, Cell host & microbe.

[32]  Yoshiki Murakami,et al.  Regulation of the hepatitis C virus genome replication by miR-199a. , 2009, Journal of hepatology.

[33]  J. Bukh,et al.  Development and characterization of hepatitis C virus genotype 1‐7 cell culture systems: Role of CD81 and scavenger receptor class B type I and effect of antiviral drugs , 2009, Hepatology.

[34]  D. Bartel.  MicroRNAs: Target Recognition and Regulatory Functions , 2009, Cell.

[35]  Stefano Volinia,et al.  Interferon modulation of cellular microRNAs as an antiviral mechanism , 2007, Nature.

[36]  Chris Sander,et al.  Cellular cofactors affecting hepatitis C virus infection and replication , 2007, Proceedings of the National Academy of Sciences.

[37]  T. Liang,et al.  Production of Infectious Hepatitis C Virus of Various Genotypes in Cell Cultures , 2007, Journal of Virology.

[38]  K. Norman,et al.  MicroRNAs: expression, avoidance and subversion by vertebrate viruses , 2006, Nature Reviews Microbiology.

[39]  P. Sarnow,et al.  Modulation of Hepatitis C Virus RNA Abundance by a Liver-Specific MicroRNA , 2005, Science.

[40]  R. Bartenschlager,et al.  Production of infectious hepatitis C virus in tissue culture from a cloned viral genome , 2005, Nature Medicine.

[41]  A. Saïb,et al.  A Cellular MicroRNA Mediates Antiviral Defense in Human Cells , 2005, Science.

[42]  D. Lavillette,et al.  Characterization of host‐range and cell entry properties of the major genotypes and subtypes of hepatitis C virus , 2005, Hepatology.

[43]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[44]  V. Dixit,et al.  RIP2 Is a Novel NF-κB-activating and Cell Death-inducing Kinase* , 1998, The Journal of Biological Chemistry.

[45]  V. Dixit,et al.  RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase. , 1998, The Journal of biological chemistry.